Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success?
- PMID: 17337677
- PMCID: PMC2083400
- DOI: 10.1136/adc.2006.094979
Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success?
Abstract
A large‐scale study has put hypertonic saline back in the spotlight
Trial registration: ClinicalTrials.gov NCT00117208.
Conflict of interest statement
Competing interests: None declared.
References
-
- Hafen G M, Ranganathan S C, Robertson C F.et al Clinical scoring systems in cystic fibrosis. Pediatr Pulmonol 200641602–617. - PubMed
-
- Kerem E, Reisman J, Corey M.et al Prediction of mortality in patients with cystic fibrosis. N Engl J Med 19923261187–1191. - PubMed
-
- Cooper P J, Robertson C F, Hudson I L.et al Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol 1990816–22. - PubMed
-
- Fuchs H J, Borowitz D S, Christiansen D H.et al Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994331637–642. - PubMed
-
- Rosenfeld M, Emerson J, Williams‐Warren J.et al Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001139359–365. - PubMed
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical